N-[2-(5-Bromo-1H-indol-3-yl)-ethyl]-acetamide

ID: ALA33800

Chembl Id: CHEMBL33800

Cas Number: 119623-06-2

PubChem CID: 44281234

Max Phase: Preclinical

Molecular Formula: C12H13BrN2O

Molecular Weight: 281.15

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC(=O)NCCc1c[nH]c2ccc(Br)cc12

Standard InChI:  InChI=1S/C12H13BrN2O/c1-8(16)14-5-4-9-7-15-12-3-2-10(13)6-11(9)12/h2-3,6-7,15H,4-5H2,1H3,(H,14,16)

Standard InChI Key:  GLPQMYRAWZFYFL-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA33800

   N-[2-(5-bromo-1H-indol-3-yl)ethyl]acetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 281.15

Molecular Weight (Monoisotopic): 280.0211

AlogP: 2.61

#Rotatable Bonds: 3

Polar Surface Area: 44.89

Molecular Species: NEUTRAL

HBA: 1

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 2.07

CX LogD: 2.07

Aromatic Rings: 2

Heavy Atoms: 16

QED Weighted: 0.89

Np Likeness Score: -0.70

References

1. Rivara S, Mor M, Silva C, Zuliani V, Vacondio F, Spadoni G, Bedini A, Tarzia G, Lucini V, Pannacci M, Fraschini F, Plazzi PV..  (2003)  Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.,  46  (8): [PMID:12672242] [10.1021/jm020982d]

2. Mor M, Rivara S, Silva C, Bordi F, Plazzi PV, Spadoni G, Diamantini G, Balsamini C, Tarzia G, Fraschini F, Lucini V, Nonno R, Stankov BM..  (1998)  Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.,  41  (20): [PMID:9748358] [10.1021/jm9810093]

Source

Source(1):

• Scientific Literature